VINATIORGA Vinati Organics Q4 FY25 results (Jan–Mar 2025) and concall
Vinati Organics delivered a strong performance in FY25, characterized by robust volume growth in its core ATBS and emerging Antioxidant segments. Despite a sharp decline in the IBB business, the company successfully expanded its margins and profitability. Management remains highly optimistic, providing aggressive growth guidance for the Antioxidant business and maintaining a steady outlook for its market-leading ATBS position.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 553 | 522 | 648 |
| EBITDA | 134 | 142 | 180 |
| Net profit | 104 | 94 | 123 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
